Literature DB >> 31178213

Nuclear localization of β-catenin and expression of target genes are associated with increased Wnt secretion in oral dysplasia.

Montserrat Reyes1, Daniel Peña-Oyarzun2, Andrea Maturana3, Vicente A Torres4.   

Abstract

OBJECTIVES: To evaluate the localization of β-catenin in oral dysplastic cells, the expression of target genes upregulated in oral dysplasia, and the role of Wnt ligands in these events.
MATERIALS AND METHODS: Subcellular localization of total and non-phosphorylated (transcriptionally active) β-catenin was evaluated by immunofluorescence and biochemical fractionation in dysplastic oral keratinocytes (DOK), non-dysplastic oral keratinocytes (OKF6), oral squamous carcinoma cells (CAL27) and primary oral keratinocytes. Tcf/Lef-dependent transcription was measured by luciferase reporter assays. Expression of target genes, survivin and cyclin D1, was evaluated by RT-qPCR and Western blotting. Wnt secretion was inhibited with the inhibitor of porcupine, C59. Wnt3a and β-catenin were evaluated in biopsies by tissue immunofluorescence.
RESULTS: Immunofluorescence and fractionation experiments showed augmented nuclear β-catenin (total and transcriptionally active) in DOK, when compared with OKF6 and CAL27 cells. Intriguingly, conditioned medium from DOK promoted nuclear accumulation of β-catenin and Tcf/Lef-dependent transcription in OKF6 and primary oral keratinocytes, suggesting the participation of secreted factors. Treatment of DOK with C59 decreased Wnt3a secretion, nuclear β-catenin and the expression of survivin and cyclin D1 at both mRNA and protein levels. Accordingly, DOK secreted higher Wnt3a levels than OKF6, and inhibition of Wnt3a secretion prevented DOK-induced Tcf/Lef-dependent transcription in OKF6. These observations were confirmed in clinical samples, since tissue immunofluorescence analysis showed simultaneous expression of Wnt3a and nuclear β-catenin in oral dysplasia, but not in healthy mucosa biopsies.
CONCLUSION: These data indicate that secretion of Wnt ligands is critical for β-catenin nuclear localization and expression of target genes in oral dysplasia.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell signaling; Keratinocyte; Oral cancer; Oral dysplasia; Survivin; Wnt; β-Catenin

Mesh:

Substances:

Year:  2019        PMID: 31178213     DOI: 10.1016/j.oraloncology.2019.05.010

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  6 in total

1.  MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.

Authors:  Te-Hsuan Jang; Wei-Chieh Huang; Shiao-Lin Tung; Sheng-Chieh Lin; Po-Ming Chen; Chun-Yu Cho; Ya-Yu Yang; Tzu-Chen Yen; Guo-Hsuen Lo; Shuang-En Chuang; Lu-Hai Wang
Journal:  J Biomed Sci       Date:  2022-06-15       Impact factor: 12.771

Review 2.  Wnt/β-Catenin Signaling in Oral Carcinogenesis.

Authors:  Montserrat Reyes; Tania Flores; Diego Betancur; Daniel Peña-Oyarzún; Vicente A Torres
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

3.  UBE2M promotes cell proliferation via the β-catenin/cyclin D1 signaling in hepatocellular carcinoma.

Authors:  Guang-Cong Zhang; Xiang-Nan Yu; Jia-Lei Sun; Ju Xiong; Yi-Jun Yang; Xue-Mei Jiang; Ji-Min Zhu
Journal:  Aging (Albany NY)       Date:  2020-02-03       Impact factor: 5.682

4.  Expression profile of components of the β-catenin destruction complex in oral dysplasia and oral cancer.

Authors:  F-J Goñi; D Peña-Oyarzún; V-A Torres; M Reyes
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2021-11-01

Review 5.  The Significance of the Dysregulation of Canonical Wnt Signaling in Head and Neck Squamous Cell Carcinomas.

Authors:  Jarosław Paluszczak
Journal:  Cells       Date:  2020-03-15       Impact factor: 6.600

6.  WNT7A Promotes EGF-Induced Migration of Oral Squamous Cell Carcinoma Cells by Activating β-Catenin/MMP9-Mediated Signaling.

Authors:  Hui Xie; Yadong Ma; Jun Li; Huixia Chen; Yongfu Xie; Minzhen Chen; Xuyang Zhao; Sijie Tang; Shuo Zhao; Yujie Zhang; Jun Du; Feimin Zhang; Luo Gu
Journal:  Front Pharmacol       Date:  2020-02-26       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.